Understanding genetic architecture of plasma lipidome could provide better insights into
lipid metabolism and its link to cardiovascular diseases (CVDs). Here, we perform genome-…

Context: Sirtuins (SIRTs) regulate cellular metabolism and mitochondrial function according
to the energy state of the cell reflected by NAD + levels. Objective: Our aim was to determine …

The impact of genetic variation on overall disease burden has not been comprehensively
evaluated. We introduce an approach to estimate the effect of genetic risk factors on disability-…

Background: Hyperlipidemia is a highly heritable risk factor for coronary artery disease (CAD).
While monogenic familial hypercholesterolemia associates with severely increased CAD …

Little is known about the genetic determinants of medication use in preventing cardiometabolic
diseases. Using the Finnish nationwide drug purchase registry with follow-up since 1995, …

Objective To investigate how obesity, insulin resistance and low-grade inflammation link to
circulating metabolites, and whether the connections are due to genetic or environmental …

Familial combined hyperlipidemia (FCH) is a complex and common familial dyslipidemia
characterized by elevated total cholesterol and/or triglyceride levels with over five-fold risk of …

Background We asked whether, after excluding familial hypercholesterolemia, individuals
with high low‐density lipoprotein cholesterol ( LDL ‐C) or triacylglyceride levels and a family …

Fibrotic diseases affect multiple organs and are associated with morbidity and mortality. To
examine organ-specific and shared biologic mechanisms that underlie fibrosis in different …

Importance Central serous chorioretinopathy (CSC) is a serous maculopathy of unknown
etiology. Two of 3 previously reported CSC genetic risk loci are also associated with AMD. …